Osteoporosis is a progressive, systemic, skeletal disease characterized
by decreased bone mass and microarchitectural deterioration of bone
tissue leading to increased bone fragility and susceptibility to
The more risk factors (eg history of fracture, advanced age,
comorbidities, etc) that are present, the greater the risk
The addition of ibandronate to adjuvant hormonal therapy provides no benefit to postmenopausal women with HR-positive breast cancer, according to early results from the phase III TEAM IIB trial (BOOG 2006-4)*.